COVID-19 in Iran: Coronavirus outbreak, measures and impact
The Islamic Republic of Iran was the first Middle East country to report a death...
Read More...
Focus:
-
![Hydroxychloroquine trial]()
A closer look at the first in human trial for a Covid-19 vaccine
With the accelerating global burden from the Covid-19 pandemic, researchers are rapidly searching for a...
Read More...
-
![methamphetamine addiction trial]()
InterveXion’s Phase I/II methamphetamine addiction trial with mAb to complete enrolment
InterveXion Therapeutics’ 126-patient Phase I/II trial of IXT-m200 to combat methamphetamine addiction is expected to close...
Read More...
-
![medday ms drug]()
MedDay’s MS drug fails in phase III trial, creating opportunity for competitors
MedDay Pharmaceuticals announced that its multiple sclerosis (MS) drug MD1003 had failed to meet its...
Read More...
-
![Asia-pacific clinical trials]()
Clinical trials data report for Asia-Pacific: Frost & Sullivan collaborates with Novotech
Business consulting firm Frost & Sullivan and Asia-Pacific CRO specialist Novotech published a report summarising the main trends and developments…
Read More…
-
![Coronavirus partnerships]()
Covid-19: Pharmaceutical companies and agencies that partnered for coronavirus vaccine development
Pharmaceutical companies from across the world along with government agencies have partnered to develop a...
Read More...
-
![]()
2018 was a top year for clinical trials for depression
Looking at depression clinical trials in the database with a start date from 2015 to...
Read More...
-
![]()
Celldex stops Phase Ib/II trial in melanoma due to GI toxicities after enrolling three patients
The study had enrolled three out of its 10-patient target when it was stopped, a...
Read More...
-
![]()
Amgen’s AMG510 combo exploration in colorectal cancer tumours poised for late 2019, early 2020
The theory behind combining AMG510 with a MEK inhibitor in CRC is that together they...
Read More...
-
![]()
UCB to conduct bridging study of UCB0107 in progressive supranuclear palsy this year
The bridging study will be necessary to provide the safety and pharmacokinetic data needed to...
Read More...
